Patents Assigned to Hazleton Biotechnologies, Inc.
  • Myeloma cell lines and uses thereof
    Patent number: 4757018
    Abstract: Myeloma cell lines adapted for growth and cloned in a serum-free medium in which human transferrin is the sole protein source are described. These cells may be fused to immunocytes to create monoclonal antibody-secreting hybridomas in the same medium.
    Type: Grant
    Filed: February 11, 1985
    Date of Patent: July 12, 1988
    Assignee: Hazleton Biotechnologies, Inc.
    Inventor: Bruce L. Brown